U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C31H34ClN3O7S3
Molecular Weight 692.266
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of KP-496

SMILES

CC(C)C1=CSC(COC2=CC(CN(CCCCNS(=O)(=O)C3=CC=C(Cl)C=C3)S(=O)(=O)C4=CC=CC=C4C(O)=O)=CC=C2)=N1

InChI

InChIKey=WMMCMKVGDPXYQS-UHFFFAOYSA-N
InChI=1S/C31H34ClN3O7S3/c1-22(2)28-21-43-30(34-28)20-42-25-9-7-8-23(18-25)19-35(45(40,41)29-11-4-3-10-27(29)31(36)37)17-6-5-16-33-44(38,39)26-14-12-24(32)13-15-26/h3-4,7-15,18,21-22,33H,5-6,16-17,19-20H2,1-2H3,(H,36,37)

HIDE SMILES / InChI

Molecular Formula C31H34ClN3O7S3
Molecular Weight 692.266
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Wed Apr 02 13:30:25 GMT 2025
Edited
by admin
on Wed Apr 02 13:30:25 GMT 2025
Record UNII
QQB95VUD4B
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
KP-496
Code English
KP-496NS
Preferred Name English
BENZOIC ACID, 2-(((4-(((4-CHLOROPHENYL)SULFONYL)AMINO)BUTYL)((3-((4-(1-METHYLETHYL)-2-THIAZOLYL)METHOXY)PHENYL)METHYL)AMINO)SULFONYL)-
Systematic Name English
S-36496
Code English
KP496
Code English
2-(4-((4-CHLOROPHENYL)SULFONYLAMINO)BUTYL-((3-((4-ISOPROPYLTHIAZOL-2-YL)METHOXY)PHENYL)METHYL)SULFAMOYL)BENZOIC ACID
Systematic Name English
Code System Code Type Description
FDA UNII
QQB95VUD4B
Created by admin on Wed Apr 02 13:30:25 GMT 2025 , Edited by admin on Wed Apr 02 13:30:25 GMT 2025
PRIMARY
PUBCHEM
11578433
Created by admin on Wed Apr 02 13:30:25 GMT 2025 , Edited by admin on Wed Apr 02 13:30:25 GMT 2025
PRIMARY
CAS
217799-03-6
Created by admin on Wed Apr 02 13:30:25 GMT 2025 , Edited by admin on Wed Apr 02 13:30:25 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY
These results indicate that KP-496 is a selective dual antagonist for LTD(4) and TXA(2) receptors.